Clinical Trials Browser

Completed × OTHER × Drug Therapy × Clear all

NCT02122185 2026-03-27

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

111 enrolled 15 charts

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

NCT04798664 2026-02-25

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Phase NA Completed

3,228 enrolled 41 charts

Lung Neoplasms, Tobacco Use Disorder, Smoking Cessation

NCT06018376 2026-02-06

LUDICAS

553 enrolled 6 charts

Lung Neoplasms, Sexual Dysfunction, Physiological

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Phase 2 Completed

14 enrolled 16 charts

Prostatic Neoplasms

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Phase 2 Completed

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT02314182 2025-12-19

GRECCAR8

Phase 3 Completed

Gastrointestinal

Rectal Neoplasms

NCT03676257 2025-12-10

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

20,033 enrolled 9 charts

Breast Neoplasms

NCT04699539 2025-12-10

Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

Phase NA Completed

96 enrolled 12 charts

Treatment

NCT05440916 2025-12-02

PRIMM

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT01927744 2025-11-26

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

Phase 2 Completed

55 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02918955 2025-11-20

UPFRONT-NECK

Phase 3 Completed

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

NCT04603586 2025-10-20

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

Phase NA Completed

119 enrolled 10 charts

Treatment

NCT01908777 2025-10-09

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Phase 2 Completed

Lymphoma, T-Cell

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Phase 1 Completed

21 enrolled 12 charts

Brain Neoplasms, Glioblastoma

NCT05775796 2025-10-01

Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT06341998 2025-09-19

SCRRYST

Phase 2/3 Completed

Neoplasms, Germ Cell and Embryonal, Endodermal Sinus Tumor

NCT07152938 2025-09-15

AVR-CHEMO

Phase NA Completed

BreastGastrointestinalLymphoidPlasma cell

Agnosia, Anxiety Disorders, Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Phase 3 Completed

289 enrolled 32 charts 1 FDA

Recurrence

NCT07127315 2025-08-17

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Breast Neoplasms

NCT06186700 2025-07-28

Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

Phase 2 Completed

Mucositis

NCT06048913 2025-07-04

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02635360 2025-07-03

Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer

Phase 2 Completed

94 enrolled 16 charts

Uterine Cervical Neoplasms

NCT04625803 2025-06-17

Neoadjuvant Therapy for Locally Advanced Colon Cancer

Phase 2 Completed

64 enrolled 11 charts

Gastrointestinal

Colonic Neoplasms

NCT06533722 2025-06-10

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Phase 2 Completed

HER2-negative Metastatic Breast Cancer

NCT06990347 2025-05-25

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

Breast Neoplasms

NCT06980792 2025-05-20

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02649829 2025-04-29

MESODEC

Phase 1/2 Completed

GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Wilms Tumor

NCT02278887 2025-03-10

TIL

Phase 3 Completed

Melanoma

NCT04997382 2025-02-25

CLASSIC5

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT04091867 2025-02-24

sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT03367299 2025-01-22

LAL2317

Phase 2 Completed

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03314740 2025-01-10

BAROCCO

Phase 2 Completed

123 enrolled 14 charts

Ovarian Neoplasms

NCT03248570 2024-11-20

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Phase 2 Completed

26 enrolled 18 charts

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03227328 2024-11-07

KENDO

Phase 2 Completed

Breast Neoplasms

NCT03985046 2024-11-07

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03355157 2024-10-01

PADMA

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

NCT00004112 2024-09-23

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Phase 3 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

Mouth Neoplasms

NCT03539406 2024-08-09

INTRO

Phase 1 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

72,408 enrolled

Kidney Neoplasms, Neoplasms, Second Primary

NCT06461598 2024-06-17

Signature for Precise Chemosensitivity Prediction in PDAC

Gastrointestinal

Pancreatic Neoplasms

NCT06292052 2024-05-14

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness

Lung Neoplasms

NCT03874897 2024-04-30

Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT02448420 2024-04-18

PATRICIA II

Phase 2 Completed

Breast Neoplasms

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00596154 2024-04-01

PCNSL

Phase 2 Completed

33 enrolled 9 charts

Lymphoma, Non-Hodgkin

NCT03757858 2024-02-07

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Phase 1/2 Completed

Neoplasm Metastasis, Neoplasms, Pelvic Neoplasms

NCT06238752 2024-02-02

RENMIN-213

Phase 2 Completed

Adenocarcinoma

NCT04568200 2024-01-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma